Cargando…
Early Treatment of COVID-19 Disease: A Missed Opportunity
Antivirals have demonstrated efficacy in treating other infectious diseases in early stages of disease, reducing morbidity, mortality, and the likelihood of onward transmission. At the time of writing, more than 1900 clinical trials are registered globally to assess the efficacy and safety of candid...
Autores principales: | Forrest, Jamie I., Rayner, Craig R., Park, Jay J. H., Mills, Edward J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553378/ https://www.ncbi.nlm.nih.gov/pubmed/33051827 http://dx.doi.org/10.1007/s40121-020-00349-8 |
Ejemplares similares
-
Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity
por: Forrest, Jamie I., et al.
Publicado: (2020) -
COVID-19: a missed opportunity for medical education
por: Tam, Wai Jia, et al.
Publicado: (2021) -
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
por: Lee, Zelyn, et al.
Publicado: (2021) -
Advancing research in pregnancy during COVID-19: Missed opportunities and momentum in the US
por: Jaffe, Elana F., et al.
Publicado: (2021) -
COVID-19 in Ethiopia: current situation, missed opportunities, and the risk of health system disruptions
por: Biadgilign, Sibhatu, et al.
Publicado: (2020)